Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of General Psychiatry
Published in: Annals of General Psychiatry 1/2013

Open Access 01-12-2013 | Primary research

Quality of life changes following inpatient and outpatient treatment in obsessive-compulsive disorder: a study with 12 months follow-up

Authors: Elisabeth Hertenstein, Nicola Thiel, Nirmal Herbst, Tobias Freyer, Christoph Nissen, Anne Katrin Külz, Ulrich Voderholzer

Published in: Annals of General Psychiatry | Issue 1/2013

Login to get access

Abstract

Background

Quality of life (QoL) is increasingly recognized as a critical outcome parameter in mental health studies. The aim of this study was to investigate different domains of the QoL in persons with obsessive-compulsive disorder (OCD) before and after a multimodal, disorder-specific in- and outpatient treatment.

Methods

Data of 73 persons with OCD treated in an inpatient setting followed by outpatient treatment were analyzed. The World Health Organization Quality of Life abbreviated (a multidimensional measure of the QoL) and the Beck Depression Inventory were administered prior to (baseline) and 12 months after the inpatient treatment (follow-up).

Results

At baseline, participants reported a significantly diminished psychological, social, physical, and global QoL compared to the German general population. Environmental QoL was not impaired in the present sample. The QoL was significantly improved at follow-up, except for social QoL, but remained below norm values. The QoL improvement was predicted by improvements of depressive symptoms.

Conclusions

The results indicate that persons with OCD suffer from a very low QoL. The QoL was significantly improved after 12 months of intensive state-of-the-art treatment. However, the QoL indices remained considerably lower than population norm values, indicating the need for additional research into novel treatment options for persons with OCD.
Appendix
Available only for authorised users
Literature
1.
Crino R, Slade T, Andrews G: The changing prevalence and severity of obsessive-compulsive disorder criteria from DSM-III to DSM-IV. Am J Psychiat. 2005, 162: 876-882. 10.1176/appi.ajp.162.5.876.CrossRefPubMed
2.
Karno M, Golding JM, Sorenson SB, Burnam MA: The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiat. 1988, 45: 1094-1099. 10.1001/archpsyc.1988.01800360042006.CrossRefPubMed
3.
Abramowitz JS, Taylor S, McKay D: Obsessive-compulsive disorder. Lancet. 2009, 374: 491-499. 10.1016/S0140-6736(09)60240-3.CrossRefPubMed
4.
Abramowitz JS: The psychological treatment of obsessive-compulsive disorder. Can J Psychiat. 2006, 51: 407-416.
5.
Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X: Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiat. 2005, 162: 151-161. 10.1176/appi.ajp.162.1.151.CrossRefPubMed
6.
Bystritsky A, Saxena S, Maidment K, Vapnik T, Tarlow G, Rosen R: Quality-of-life changes among patients with obsessive-compulsive disorder in a partial hospitalization program. Psychiatr Serv. 1999, 50: 412-414.CrossRefPubMed
7.
Norberg MM, Calamari JE, Cohen RJ, Riemann BC: Quality of life in obsessive-compulsive disorder: An evaluation of impairment and a preliminary analysis of the ameliorating effects of treatment. Depress Anxiety. 2008, 25: 248-259. 10.1002/da.20298.CrossRefPubMed
8.
Bystritsky A, Liberman RP, Hwang S, Wallace CJ, Vapnik T, Maindment K, Saxena S: Social functioning and quality of life comparisons between obsessive-compulsive and schizophrenic disorders. Depress Anxiety. 2001, 14: 214-218. 10.1002/da.1069.CrossRefPubMed
9.
Moritz S, Rufer M, Fricke S, Karow A, Morfeld M, Jelinek L, Jacobsen D: Quality of life in obsessive-compulsive disorder before and after treatment. Compr Psychiat. 2005, 46: 453-459. 10.1016/j.comppsych.2005.04.002.CrossRefPubMed
10.
Hollander E, Stein DJ, Fineberg NA, Marteau F, Legault M: Quality of life outcomes in patients with obsessive-compulsive disorder: relationship to treatment response and symptom relapse. J Clin Psychiat. 2010, 71: 784-792. 10.4088/JCP.09m05911blu.CrossRef
11.
Diefenbach GJ, Abramowitz JS, Norberg MM, Tolin DF: Changes in quality of life following cognitive-behavioral therapy for obsessive-compulsive disorder. Behav Res Ther. 2007, 45: 3060-3068. 10.1016/j.brat.2007.04.014.CrossRefPubMed
12.
Stewart SE, Stack DE, Farrell C, Pauls DL, Jenike MA: Effectiveness of intensive residential treatment (IRT) for severe, refractory obsessive-compulsive disorder. J Psychiat Res. 2005, 39: 603-609. 10.1016/j.jpsychires.2005.01.004.CrossRefPubMed
13.
Cordioli AV: Cognitive-behavioral therapy in obsessive-compulsive disorder. Rev Bras Psiquiatr. 2008, 30: S65-S72.CrossRefPubMed
14.
Tenney NH, Denys DAJP, van Megen HJGM, Glas G, Westenberg HGM: Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder. Int Clin Psychopharm. 2003, 18: 29-33.CrossRef
15.
Koran LM, Bromberg D, Hornfeldt CS, Shepski JC, Wang S, Hollander E: Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorder. Compr Psychiat. 2010, 51: 373-379. 10.1016/j.comppsych.2009.10.001.CrossRefPubMed
16.
Masellis M, Rector NA, Richter MA: Quality of life in OCD: differential impact of obsessions, compulsions, and depression comorbidity. Can J Psychiat. 2003, 48: 72-77.
17.
Mawson D, Marks IM, Ramm L: Clomipramine and exposure for chronic obsessive-compulsive rituals: III. Two year follow-up and further findings. Brit J Psychiat. 1982, 140: 11-18. 10.1192/bjp.140.1.11.CrossRefPubMed
18.
Watanabe N, Furukawa TA, Chen J, Kinoshita Y, Nakano Y, Ogawa S, Funayama T, Ietsugu T, Noda Y: Change in quality of life and their predictors in the long-term follow-up after group cognitive behavioral therapy for social anxiety disorder: a prospective cohort study. BMC Psychiatry. 2010, 10: 81-10.1186/1471-244X-10-81.PubMedCentralCrossRefPubMed
19.
Chan SW, Chiu HFK, Chien W, Goggins W, Thompson D, Hong B: Predictors of change in health-related quality of life among older people with depression: a longitudinal study. Int Psychogeriatr. 2009, 21: 1171-1179. 10.1017/S1041610209990950.CrossRefPubMed
20.
Skevington SM, Lotfy M, O’Connell KA: The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004, 13: 299-310.CrossRefPubMed
21.
Angermeyer MC, Kilian R, Matschinger H: WHOQOL-100 und WHOQOL-BREF. 2000, Handbuch für die deutschsprachige version der WHO instrumente zur erfassung von lebensqualität. Göttingen: Hofgrefe
22.
Sprinkle SD, Lurie D, Insko SL, Atkinson G, Jones GL, Logan AR, Bissada NN: Criterion validity, severity cut scores, and test-retest reliability of the beck depression inventory-II in a university counseling center sample. J Couns Psychol. 2002, 49: 381-385.CrossRef
23.
Kühner C, Bürger C, Keller F, Hautzinger M: Reliabilität und validität des revidierten beck-depressionsinventars (BDI-II). Nervenarzt. 2007, 78: 651-656. 10.1007/s00115-006-2098-7.CrossRefPubMed
24.
Derogatis LR, Fitzpatrick M: The SCL-90-R, the Brief Symptom Inventory (BSI), and the BSI-18. The Use of Psychological Testing for Treatment Planning and Outcomes Assessment: Volume 3: Instruments for Adults. Edited by: Maruish MEM. 2004, New Jersey: Lawrence Erlbaum Associates Publishers, 1-41. 3
25.
Hohagen F, Winkelmann G, Rasche-Räuchle H, Hand I, König A, Münchau N, Hiss H, Geiger-Kabisch C, Käppler C, Schramm P, Rey E, Aldenhoff J, Berger M: Combination of behaviour therapy with fluvoxamine in comparison with behaviour therapy and placebo: results of a multicentre study. Brit J Psychiat. 1998, 173: 71-78.
26.
Cohen J: Statistical Power Analysis for the Behavioral Sciences. 1988, New Jersey: Lawrence Erlbaum
27.
Jacobson NS, Truax P: Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991, 59: 12-19.CrossRefPubMed
28.
Eisen JL, Mancebo MA, Pinto A, Coles ME, Pagano ME, Stout R, Rasmussen SA: Impact of obsessive-compulsive disorder on quality of life. Compr Psychiat. 2006, 47: 270-275. 10.1016/j.comppsych.2005.11.006.PubMedCentralCrossRefPubMed
29.
Albert U, Maina G, Bogetto F, Chiarle A, Mataix-Cols D: Clinical predictors of health-related quality of life in obsessive-compulsive disorder. Compr Psychiat. 2010, 51: 193-200. 10.1016/j.comppsych.2009.03.004.CrossRefPubMed
30.
Skevington SM, McCrate FM: Expecting a good quality of life in health: assessing people with diverse diseases and conditions using the WHOQOL-BREF. Health Expect. 2012, 15: 49-62. 10.1111/j.1369-7625.2010.00650.x.CrossRefPubMed
31.
Koran LM, Thienemann ML, Davenport R: Quality of life for patients with obsessive-compulsive disorder. Am J Psychiat. 1996, 153: 783-788.CrossRefPubMed
32.
Stengler-Wenzke K, Kroll M, Matschinger H, Angermeyer MC: Subjective quality of life of patients with obsessive-compulsive disorder. Soc Psychiatry Psychiatr Epidemiol. 2006, 41: 662-668. 10.1007/s00127-006-0077-8.CrossRefPubMed
33.
Eisen JL, Pinto A, Mancebo MC, Dyck IR, Orlando ME, Rasmussen SA: A 2-year prospective follow-up study of the course of obsessive-compulsive disorder. J Clin Psychol. 2010, 71: 1033-1039.
34.
Skoog G, Skoog I: A 40-year follow-up of patients with obsessive-compulsive disorder. Arch Gen Psychiat. 1999, 56: 121-127. 10.1001/archpsyc.56.2.121.CrossRefPubMed
35.
Grabe HJ, Hartschen V, Welter-Werner E, Thiel A, Freyberger HJ, Kathmann N, Boerner R, Hoff P: Entwicklung eines AMDP-moduls zur erfassung von zwangssymptomen. Kozeptualisierung und empirische ergebnisse. Fortschr Neurol Psychiatr. 1998, 66: 201-206. 10.1055/s-2007-995256.CrossRefPubMed
36.
Ramirez A, Ekselius L, Ramklint M: Axis V—global assessment of functioning scale (GAF), further evaluation of the self-report version. Eur Psychiat. 2008, 23: 575-579. 10.1016/j.eurpsy.2008.05.001.CrossRef
Metadata
Title
Quality of life changes following inpatient and outpatient treatment in obsessive-compulsive disorder: a study with 12 months follow-up
Authors
Elisabeth Hertenstein
Nicola Thiel
Nirmal Herbst
Tobias Freyer
Christoph Nissen
Anne Katrin Külz
Ulrich Voderholzer
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Annals of General Psychiatry / Issue 1/2013
Electronic ISSN: 1744-859X
DOI
https://doi.org/10.1186/1744-859X-12-4

Other articles of this Issue 1/2013

Annals of General Psychiatry 1/2013 Go to the issue

Primary research

A theory-based educational intervention to pediatricians in order to improve identification and referral of maternal depression: a quasi-experimental study

Primary research

Psychiatrists’ perceptions of the clinical importance, assessment and management of patient functioning in schizophrenia in Europe, the Middle East and Africa

Primary research

Correlational study: illness representations and coping styles in caregivers for individuals with schizophrenia

Review

Electroconvulsive therapy use in adolescents: a systematic review

Primary research

Therapeutic alliance in early schizophrenia spectrum disorders: a cross-sectional study

Primary research

Reasons and clinical outcomes of antipsychotic treatment switch in outpatients with schizophrenia in real-life clinical settings: the ETOS observational study